| 501/553 | US=2-A / Biol/Mol Fischer U, Schulze-Osthoff K. Molecular targets and therapeutics: current therapeutic strategies targeting caspases in disease. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 862-90. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; ESTRATEGIAS TERAPEUTICAS; CASPASES; CATALISADORES DE MORTE; RESPOSTAS IMUNE INATA; BIOQUIMICA DE CASPASES |
| 502/553 | US=2-A / Biol/Mol Stridh H, Bykov VJN, Selivanova G, Wiman KG. Molecular targets and therapeutics: cancer therapy by reactivation of the p53 apoptosis pathway. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 891-912. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; CANCER. TERAPIA; REATIVACAO DA APOPTOSE; VIA P53; TERAPIA GENETICA |
| 503/553 | US=2-A / Biol/Mol Armstrong RC, Belli BA, Deckwerth TL. Molecular targets and therapeutics: small-molecular inhibitors of the of apoptosis proteins. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 913-32. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBIDORES DA PEQUENA MOLECULARES DE PROTEINAS; APOPTOSE |
| 504/553 | US=2-A / Biol/Mol Clarke PA, Powers M, Workman P. Molecular targets and therapeutics: inhibition of the molecular chaperone heat shock protein 90 in cancer: consequences for the regulation of survival signaling and induction of cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 933-65. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBICAO DA CHAPERONE; CHOQUE TERMICO 90; CANCER; REGULACAO DA SINALIZACAO; SOBREVIVENCIA; INDUCAO DE MORTE CELULAR; PROTEINA HSP90 |
| 505/553 | US=2-A / Biol/Mol Graville CA, Memmott RM, Gills JJ, Dennis PA. Molecular targets and therapeutics: targeting the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin pathway. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 966-96. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; RAPAMICINA; FOSFOINOSITIDE-3-QUINASE; AKT; P13K/AKT |
| 506/553 | US=2-A / Biol/Mol Kullmann S, Teichgräber V, Bollinger CR, Gulbins E. Molecular targets and therapeutics: ceramide signaling in apoptosis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 997-1013. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; SINALIZACAO DE CERAMIDA; APOPTOSE; CANCER. TERAPIA |
| 507/553 | US=2-A / Biol/Mol Marks PA. Molecular targets and therapeutics: histone deacetylase inhibitors: development as anticancer agents. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1014-32. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBIDORES DE HISTONA DEACETILASE; AGENTES ANTICANCER; ESTRUTURA DA CROMATINA; HDAC; ENSAIOS CLINICOS |
| 508/553 | US=2-A / Biol/Mol Rieger J, Weller M. Molecular targets and therapeutics: exploiting apoptosis pathways for glioblastoma therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1033-48. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; VIAS DE APOPTOSE; GLIOBLASTOMA. TERAPIA; PROTEINA P53; FAMILIA BCL-2; FATOR DE CRESCIMENTO DERIVADO DE PLAQUETAS; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FOSFOINOSITIDE-3-KINASE |
| 509/553 | US=2-A / Biol/Mol Jendrossek V, Belka C. Molecular targets and therapeutics: radiation therapy and apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1049-86. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; RADIOTERAPIA; APOPTOSE; MORTE CELULAR; P53; CERAMIDA; NECROSE |
| 510/553 | US=2-A / Biol/Mol Becker J, Wilting J, Schweigerer LL. Molecular targets and therapeutics: tumor angiogenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1087-106. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; ANGIOGENESE TUMORAL; VASCULOGENESE; LINFANGIOGENESE; HEMANGIOGENESE; FATORES DE HIPOXIA INDUZIDO; ANGIOPOIETINAS; FATORES DE CRESCIMENTO FIBROBLASTICO; INTEGRINAS |
| 511/553 | US=45 / Urologia Lane T, Strefford J, Oliver T. An update on biotechnology in the assessment of prostate cancer. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 3-16. ISBN 978-1-4051-0752-9. CANCER DE PROSTATA; BIOTECNOLOGIA; GENOMICA DO CANCER DE PROSTATA; HIBRIDIZACAO IN SITU FLUORESCENTE; HIBRIDACAO GENOMICA COMPARATIVA; MICROARRAYS GENOMICOS; CARIOTIPAGEM ESPECTRAL; EPIGENETICA; PERFIL DE EXPRESSAO; PROTEOMICOS |
| 512/553 | US=45 / Urologia Barthelmes L, Gateley CA. What can we learn from breast cancer?. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 17-25. ISBN 978-1-4051-0752-9. CANCER DE PROSTATA; CANCER DE MAMA; CANCER DE MAMA. PROGNOSTICO; CANCER DE MAMA. EPIDEMIOLOGIA; CANCER DE MAMA. GENETICA; CANCER DE MAMA. TERAPIA CIRURGICA; CANCER DE MAMA. TRIAGEM |
| 513/553 | US=45 / Urologia Brehmer B, Makris A, Jakse G. New serum markers for prostate cancer. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 26-39. ISBN 978-1-4051-0752-9. CANCER DE PROSTATA; MARCADORES SERICOS; MARCADORES NEUROENDOCRINOS; FATOR DE CRESCIMENTO INSULINICO; CITOCINAS; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; FATOR DE TRANSFORMACAO DO CRESCIMENTO BETA; INTERLEUCINA-6; METALOPROTEINASES DA MATRIZ; PROTEOMICA DE SORO |
| 514/553 | US=45 / Urologia Ishii K, Hayward S. The history of tissue recombination technology: current and future research. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 40-52. ISBN 978-1-4051-0752-9. CANCER DE PROSTATA; TECNOLOGIA DE RECOMBINACAO DO TECIDO; MODELAGEM IN VIVO; INTERACAO ESTROMA-EPITELIO |
| 515/553 | US=45 / Urologia Mason M, Staffurth J. Why we cannot use the results of non-randomised trials to inform us about treatment for early prostate cancer. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 53-61. ISBN 978-1-4051-0752-9. |
| 516/553 | US=45 / Urologia Djavan B, Dobrovits M, Marberger M. Equivocal PSA results and free total PSA ratio. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 65-75. ISBN 978-1-4051-0752-9. CANCER DE PROSTATA; PSA; PSA LIVRE TOTAL; RAZAO PSA LIVRE/TOTAL; CALICREINA 2 HUMANA GLANDULAR |
| 517/553 | US=45 / Urologia Varma M, Griffiths D. Equivocal prostate needle biopsies. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 76-84. ISBN 978-1-4051-0752-9. |
| 518/553 | US=45 / Urologia Clements R. Prostate biopsy: how many cores and where from?. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 85-96. ISBN 978-1-4051-0752-9. |
| 519/553 | US=45 / Urologia Beese G, Edmunds C. Counselling patients with early prostate cancer. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 97-111. ISBN 978-1-4051-0752-9. |
| 520/553 | US=45 / Urologia Niall O, Kearsley J. The role of pelvic node dissection in prostate cancer. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 112-24. ISBN 978-1-4051-0752-9. CANCER DE PROSTATA; DISSECACAO DO NO PELVICA; LINFADENECTOMIA; IMAGEM; NOMOGRAMA; TECNICAS OPERATORIAS |